Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus-Reference-Cited by-同舟云学术

Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus

Published:2017-01-05 Issue:7 Volume:8 Page:12108-12119
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Yu Tian-Zhu¹²,Zhang Wen¹²,Liu Qing-Xin¹²,Li Wen-Hui³,Ma Jing-Qin¹²,Zhang Zi-Han¹²,Yang Min-Jie¹²,Wang Jian-Hua¹²,Chen Bing⁴,Zeng Shao-Chong⁴,Luo Jian-Jun¹²,Liu Ling-Xiao¹²,Yan Zhi-Ping¹²

Affiliation:

1. Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China

2. Shanghai Institute of Medical Imaging, Shanghai, China

3. Department of Interventional Radiology, Yancheng Third People's Hospital, Southeast University, Yancheng, China

4. Department of Radiotherapy, Zhongshan Hospital, Fudan University, Shanghai, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic infarction occurred after 125I particle stent treatment for hepatocellular carcinoma with portal vein tumor thrombus: A case report;Journal of Cancer Research and Clinical Oncology;2024-06-17

2. Hepatic infarction occurred after 125 I particle stent treatment for hepatocellular carcinoma with portal vein tumor thrombus: A case report;2024-03-12

3. Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension;World Journal of Gastrointestinal Surgery;2022-06-27

4. TACE with portal vein radioactive seeds for HCC with portal vein tumor thrombus: a meta-analysis;Minimally Invasive Therapy & Allied Technologies;2022-03-03

5. Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis;World Journal of Surgical Oncology;2022-02-02